Uncategorized Archives - Page 16 of 248

TuesdayAug 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates ‘Strategically Important’ New Patent Granted in the US

Lexaria recently celebrated the receipt of its 35th overall granted patent worldwide when the USPTO recently awarded US patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine” The company described the new patent as “strategically important” The patent positions the company to tap into the growing oral nicotine market and offers protection in one of the world’s leading oral nicotine markets This patent could also lead to additional subsequent patents from within this family Lexaria’s DehydraTECH-nicotine formulation is patent granted for oral nicotine delivery in the US, Canada, and Australia When Lexaria Bioscience (NASDAQ: LEXX), a global innovator…

FridayAug 04, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Incorporates New Subsidiary, Lexaria Nutraceutical Corp., for Non-Pharmaceutical, Non-Nicotine, and Non-Cannabis DehydraTECH(TM) Formulations

Lexaria Nutraceutical Corp. will keep Lexaria’s overall strategy of maximizing the company’s patented DehydraTECH(TM) technology in various markets, excluding pharmaceutical, nicotine, and cannabis molecules Lexaria Pharmaceutical Corp.’s licensing was amended so as to solely focus on pharmaceutical formulations excluding nicotine Lexaria announced in early May that its nicotine trial, NIC-H22-1, had completed dosing with results expected in the near future NIC-H22-1 is anticipated to intercede the oral nicotine pouch market, which had a global value of $2.33 billion in 2020, and is expected to grow to $21.84 billion by 2027 Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug…

FridayJul 28, 2023 4:20 pm

420 with CNW — How to Make Marijuana Websites Compliant with ADA Requirements

For more than 30 years, the Americans with Disabilities Act (ADA) has protected people with disabilities from discrimination in all public places on the basis of their disabilities. This legislation ensures that all public places, including schools, public transportation and office buildings, are designed to accommodate the needs of people living with disabilities. Now that ecommerce is one of the most dominant forms of trade across the country, businesses in America’s state-legal cannabis sector should also make their websites ADA-compliant. In many ways, websites have replaced the brick-and-mortar stores of old. They allow people to visit different “shops” and make…

FridayJul 28, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Newly Granted Patent for DehydraTECH(TM)–Nicotine by United States Patent and Trademark Office

Lexaria’s new patent includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches The global oral nicotine pouch market was valued at $4.69 billion in 2022 and is expected to grow to $11.91 billion by 2029, driven by the growing ban on e-cigarettes worldwide The white pouch category is one of the fastest-growing, tobacco-free alternatives to smoking and vaping – growing at a CAGR of 13.4% Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that the United…

WednesdayJul 26, 2023 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Set to be Used in Multi-Billion Dollar Markets; On Track to have 2023 as Best Year Yet

Lexaria’s patented DehydraTECH(TM) technology enhances the performance of several categories of fat-soluble active molecules and drugs across oral and/or topical product formats This unique approach to drug delivery has earned Lexaria a total of 35 patents, with many patents pending worldwide The company continues active discussions with multi-billion dollar companies for the potential use of DehydraTECH in their commercial pursuits Lexaria is also actively seeking commercial partners during 2023 and 2024 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is out on an ambitious move to address conditions with high unmet needs. This focus has allowed them…

MondayJul 24, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Publishes Eighth Peer-Reviewed Article in International Journal of Molecular Science

The article covers the concentration of cannabidiol in hypertensive women and men using the company’s patented DehydraTECH(TM)-processed CBD The global cardiovascular drugs market is expected to grow from $146.51 billion in 2021, reaching $173.48 billion in 2026, growing at a CAGR of 3.1% The article supports Lexaria’s efforts as it pursues IND status from the FDA for DehydraTECH-CBD as a potential treatment for hypertension Company is planning to begin preparations for a clinical trial that could start as early as the fourth quarter Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that its groundbreaking research…

ThursdayJul 20, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Building a Robust and Growing International Patent Portfolio for DehydraTECH(TM) in Support of Commercial Opportunities

Lexaria is a global innovator in drug delivery platforms with an expanding portfolio of patents that currently stands at 34 granted patents and many patents pending worldwide These patents pertain to the company’s method of improving bioavailability and taste as well as the use of DehydraTECH(TM) as a delivery platform for a wide variety of active pharmaceutical ingredients (“APIs”) The company has, since June 2015, simultaneously filed the US utility patent application and an international patent application under the Patent Cooperation Treaty (“PCT”) procedure, both through the USPTO The PCT procedure has made the process of initiating international patent applications…

MondayJul 17, 2023 12:00 pm

The Much-awaited Cannabis Drinks Expo Returns to Chicago

Cannabis Drinks Expo to be held in Chicago, IL on August 1, 2023. The much-awaited event is set to bring together the greatest and brightest minds in the cannabis-infused beverages industry. As the leading event for the cannabis drinks industry, Cannabis Drinks Expo (“CDE”) offers a unique platform for distributors, retailers, and businesses, to network, learn, and grow. The Expo will feature a wide range of product demos, educational seminars, and networking opportunities. The Cannabis Drinks Expo 2023 will provide a diverse mix of exciting features, including: A spacious exhibit hall to enable product exhibition for brands An educational session…

FridayJul 14, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Increases Bioavailability in Lipophilic Drugs for Potential Hypertension, Epilepsy Treatments

The bioavailability enhancement technologies and services market is expected to reach $10 billion by 2035, growing at a CAGR of approximately 11% Drug developers are shifting focus to the development of lipophilic drug compounds, which increases bioavailability DehydraTECH-enabled drugs improve the speed of onset, increase bioavailability, increases brain absorption, and reduces drug administration costs Lexaria’s DehydraTECH has 34 patents granted worldwide and many more pending across several categories of fat-soluble active molecules and drugs The company operates through four separate subsidiaries to explore the potential and options for the use of DehydraTECH in respective industries Bioavailability is the ability of…

FridayJul 14, 2023 4:20 am

420 with CNW — Lawmakers Author Amendments to Change Cannabis Rules for Security Personnel, Military Recruits

Past and current cannabis use still comes with a myriad of disadvantages for people in certain fields. Even though dozens of states now allow medical and recreational cannabis use, federal law still prohibits cannabis use. As a result, applicants and employees who work in certain fields or agencies often face stringent zero-tolerance drug policies that do not allow cannabis use regardless of local state law. Professional athletes in most major sports, truck drivers and army recruits are among the classes of individuals that are subject to workplace drug tests and can face termination for failed drug tests and, in some…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized